SlideShare a Scribd company logo
1 of 43
Emergency Management of
Congestive Heart Failure in
Small Animal Practice
**Name**, DVM, DACVIM-Cardiology
**Date**
Outline
• Cardiac Auscultation and History
–Useful tools for distinguishing cardiac
and respiratory disease
• Radiographs
• Pathophysiology of Heart Failure
• Treatment of Heart Failure
Cardic Auscultation: Tips
• Take your time
• Adequately restrain
• Minimize panting, growling, purring
• Focus on heart sounds first, breath sounds second
• Develop a repeatable pattern
• Listen for 3rd heart sounds (clicks, gallops)
• Consider the signalment of the patient
– Common things happen commonly
– Congenital vs. Acquired
– Breed-specific defects
Cardiac Auscultation:
Quick Review
• Determine heart rate and rhythm
• Correlate with femoral pulses
• Auscult over all heart valves
– Cranially - PDAs in big dogs
• Normal Sounds
– S1 - closure of MV and TV
• Onset of systole
• High frequency, PMI left apex
• Pulse occurs just after S1
– S2 - closure of AoV and PV
• Onset of diastole
• High frequency, PMI left base
Cardiac Auscultation:
Quick Review
• Transient Heart Sounds
– Systolic Click
• Dogs - usually associated with DMVD (prolapse of AMVL)
• Cats - hyperdynamic function, systolic contact of LV walls
– S3 Gallop (ventricular gallop)
• Low frequency
• Represents ventricular stiffness
(diastolic dysfunction - reduced compliance while filling)
• Caused by sudden termination of expansion of LV walls during period of rapid
ventricular filling
• HCM, DCM, Severe DMVD
– S4 Gallop (atrial gallop)
• Low frequency
• Represents ventricular stiffness
• Caused by atria trying to force blood into an already over-distended ventricle; atria
forcing blood into stiff ventricle
(atrial contraction - late ventricular diastole)
• HCM
• Can also hear S4 with some 3rd degree AVB
Cardiac Auscultation:
Quick Review
• Heart Murmurs
– Timing
• Systolic - b/w S1 and S2
(“lub-shh-dub”)
• Diastolic - after S2
(“lub-dub-shh”)
• Continuous
– PMI (base vs. apex, L vs R)
– Intensity (I-VI)
– Quality
• Regurgitant = plateau shape
– MR, TR
• Ejection = crescendo-decrescendo
– SAS, PS
• Machinery (PDA)
• Decrescendo (VSD, MR, TR)
Cardiology Auscultation:
Quick Review
• I - faint, requires
concentration/quiet room
• II - soft, consistently
ausculted over 1 valve area
• III - radiates on the same
side of the chest
• IV - radiates to both sides
of the chest
• V - loud with palpable
precordial thrill
• VI - audible with
stethoscope off chest wall
Cardiac Auscultation: Summary
• Slow down and take your time
• It matters - YOU are the gate keeper
• Making the correct diagnosis makes a difference
in outcome and survival
• 30% of Boxers, 1st sign to owner = SCD
• Does the presence of crackles = CHF?
• Document…Document…Document
– Vital signs and trends matter
– Can you explain changes?
• If present, when did arrhythmia start?
Dyspneic Patient:
Recognizing Breathing Patterns
• Upper Airway Disease
– Obstructive breathing pattern
• Long, slow inspiration
– Exception - intrathoracic obstruction can cause expiratory distress
– Narrowing of airway causes reduced and turbulent airflow
– Animal works harder to breathe against obstruction exacerbating edema and
inflammation - vicious cycle
• Stridor or Stertor
• Increased RE +/- abdominal component
• Orthopnea
– +/- Hyperthermia
– Auscultation
• Referred upper airway sounds, be sure to listen over trachea
• Obstructions can cause non-cardiogenic pulmonary edema (crackles)
Dyspneic Patient:
Recognizing Breathing Patterns
• Lower Airway Disease
– Expiratory distress
• Normal inspiration, exaggerated and prolonged expiration
• Edema and cellular infiltrates of bronchiole walls lead to thickening and
weakening of bronchial walls, excessive secretion, mucus plugs
• Narrowing causes acute bronchospasm
• As animal inhales, radial traction on the lungs pull the airways open and allows
air to enter alveolus
• As animal exhales, negative intrathoracic pressure causes airways to collapse,
trapping air in alveolus
– Alveolus full on next inspiration - reduced gas exchange
– Marked expiratory abdominal “push”
– Cats - cough (“coughing up hairballs”)
– Auscultation
• Expiratory wheezes
• Loud crackles
• No murmur
– Exception - presence of cor pulmonale or concurrent cardiac disease
Dyspneic Patient:
Recognizing Breathing Patterns
• Pulmonary Parenchymal Disease
– No specific respiratory pattern
– Respirations usually short, rapid, and deep
• Can mimic nearly any respiratory pattern
– +/- Abdominal component
– Dogs - cough
– Auscultation
• Soft crackles
– Sound of collapsed alveoli and lower airways “popping” open at end-
inspiration (indicate fluid-filled alveoli)
– Fluid - water, hemorrhage, pus
• +/- Murmur
Dyspneic Patient:
Recognizing Breathing Patterns
• Pleural Space Disease
– Restrictive breathing pattern
• Short, shallow, and rapid respirations
– Presence of air/fluid/organs/masses prevents expansion of
lungs
– Intrapleural pressure > Intrapulmonary pressure
» Causes increased tidal volume - animals must breathe
faster that normal to maintain minute volume
– Auscultation
• Dull lung +/- heart sounds
– Fluid - lungs loudest dorsal, dull ventral
– Air - lungs loudest ventral, dull dorsal
CARDIAC RESPIRATORY
Cough Soft +/- productive (mucus)
Occurs at rest
Harsh/honking
Occurs w/ activity/excitement
Activity  +/- Exercise intolerance Normal
Weight/BCS +/- Weight loss +/- Obese
Lungs Sounds Normal to  BV sounds
+/- Soft crackles (dyspneic)
 BV sounds (pleural effusion)
Normal to  BV sounds
+/- Loud crackles (eupneic)
+/- Wheezes
RR/RE/Pattern Usually short, rapid, deep +/-
abdominal effort
Exaggerated, prolonged expiration
+/- exp abd. push
HR/Rhythm Normal to Sinus Tachycardia
Possible arrhythmia
Normal to sinus bradycardia
+/- RSA
Murmur Often L apex in dogs +/- Cor pulmonale, Concurrent
cardiac disease (R vs L?)
CXR Interstitial to alveolar pattern
LAE
Bronchial and nodular patterns -
unlikely CHF
Bronchial, Broncho-interstitial
pattern
Peri-bronchial enhancement
Cardiac vs. Respiratory -
Dogs
• Causes of dyspnea
– Bronchitis
– Collapsing airway disorders
– Pulmonary interstitial disease (IPF)
– Pulmonary hypertension
– Pneumonia
• Cardiac cough = “hack/gag”
– Cardiomegaly and bronchial compression
– RR should be normal
• Sequence of pulmonary edema:
– Perihilar  Cd-D (R then L) Cr-V
– Resolves in reverse order w/ Tx
Cardiac vs. Respiratory - Cats
• Causes of Dyspnea
– CHF
– Asthma / Inflammatory
bronchial disease
– Mycoplasma
– Pneumonia
• CHF Origin Pulmonary
Infiltrates (usually)
– Cardiomegaly
– No bronchial pattern
– Can put edema anywhere
• Cardiac Origin Pleural Effusion
– TP < 4.5 g/dL
– Mixed cell population with low
TCC
– No bacteria
• Arrhythmias
– CV disease
– Hypoxia (global or local)
– Metabolic disease
– Drugs / Toxins
– Infection (sepsis)
– Autonomic disease (usuall
diagnosis of exclusion
History and Presenting Complaint
• Early Signs of CHF
– Dogs
• Exercise intolerance
• +/-Coughing
– Cats
• Hiding, decreased
appetite, behavioral
change
– Both
• Increase
sleeping/resting RR
• Late Signs of CHF
– Rapid breathing
– Exaggerated chest
and abdominal motion
to respiration
– Extended head/neck
– Coughing up pink
foam (pulmonary
edema)
Chest Radiographs:
Quick Review
Chest Radiographs:
Quick Review
• <3 ICS - Avg Dog
– <3.5 - Small Breeds
– < 2.5 - Deep-Chested
• A = 1/3-1/4 (A+B)
• B = 2/3-3/4 (A+B)
• Cats - <70% height of chest;
< 2-3 ICS
• Greatest horizontal
dimension should be
<2/3 chest dimension at
that location
• Cats - <50% width of
chest
Chest Radiographs: Quick Review
• Normal dogs:
8.5-10.7
(9.7 +/- 0.5)
• Boxers:
10.3-12.6
• Labrador Retrievers:
9.7-11.7
• CKCS:
9.9-11.7
• Cats:
6.7-8.1 (mean 7.5)
Cat in a Box Radiograph Trick
Ok….so it’s CHF…
Now what???
Congestive Heart Failure
• Syndrome, not a
disease
– Abnormality of
cardiac function that
results in the failure
of the heart to pump
blood at a rate
commensurate with
requirements of
metabolizing tissues
CHF - Classification
• Forward Failure
– Signs result from low CO and inadequate tissue perfusion
– Weakness, lethargy, pre-renal azotemia
• Backward Failure
– Failure of heart to empty blood from the veins - leading to
elevated venous and capillary pressures
– Pulmonary edema, ascites, pleural effusion
• Cardiogenic Shock
– Signs of forward and backward failure + systemic
hypotension
CHF: Classification
NYHA
Class I
(Mild)
Asymptomatic; Heart disease present but no CS
Class II
(Mild)
CS present with strenuous activity; Comfortable at rest
Class III
(Moderate)
CS with routine daily activities and mild exercise; Comfortable at rest
Class IV
(Severe)
CS severe, even at rest; Requires hospitalization
ACVIM 2009 Consensus Statement
A Dogs are risk for CHF; No apparent structural abnormality; No murmur
B-1 Structural heart disease present; Never had signs of CHF; Asymptomatic
B-2 Asymptomatic; Hemodynamically significant, remodeling noted on echo
C Past or current signs of CHF assoc w/ structural heart disease
D End stage heart disease; CHF refractory to standard therapy
CHF - Mechanisms
• 5 Mechanisms of CHF
– Volume overload
• MR, PDA
– Pressure overload
• SAH, SAS, PS
– Myocardial failure
• DCM
– Diastolic dysfunction
• HCM
– Arrhythmias
• AFib, SVT, VT
CHF - CV System Priorities
• Priorities of the CV System
– Maintain normal systemic BP
– Maintain normal tissue blood flow
– Maintain normal systemic and pulmonary capillary
pressures
• Why does the CV system have priorities?
– 3 critical vascular beds in the body (brain, heart, kidneys)
have high innate resistance to blood flow
• Ie. They need high pressures to force blood through them
CHF - Consequences
• CHF results in reduction of cardiac output - triggers
cascades of physiologic events to restore BP
(CV System 1st priority)
– Sympathetic stimulation of the heart
– Vasoconstriction
– Redistribution of blood flow
• SNS
• RAAS
• Vasopressin
• Vascular endothelial systems
– Na/H2O Retention
• Changes in RBF
• Aldosterone
• Vasopressin
• Inhibition of natriuretic hormones
CHF - Systems altered…
What’s the harm?
• So, if these events are beneficial, why do we try to
block them with medications?
– No permanent harm if systems return to normal
– Chronic activation - physiologic balance shifts toward
• Vasoconstriction
• Na retention
• Mediators of inflammation
• Mediators of tissue growth
• Remodeling/fibrosis
– Structural and functional damage to heart muscle
CHF - ER Management
• Goals
– Reduce venous congestion, edema,
and effusion formation
– Increase CO
– Normalize HR and rhythm
– Address forward failure signs
(hypotension, hypothermia)
• O2
– Pulmonary edema can case life-threatening hypoxemia d/t decreased ability
of O2 to diffuse from alveoli into pulmonary capillaries
– Increased inspired O2 concentration increases pressure gradient of O2 from
alveoli to capillaries
– Emergency - 60-100% FiO2
– Chronic O2 therapy - 35-40% FiO2
Methods for Supplemental
O2 Delivery
• Blow-by O2
• O2 Hood (temporary treatment)
– Place head inside plastic bag; O2 tubing through small hole in front of bag;
Back of bag left open for gas to escape; Monitor temp.
– Provides 85-95% O2
• O2 Collar (short or long-term treatment)
– Cover ventral 50-75% E-collar with plastic wrap; E-collar should be 1 size
larger than normally used; O2 tubing placed along inside of collar and taped
ventrally
– O2 concentration up to 80% can be achieved
– Flow rate of 1L / 10kg of BW usually provides adequate FiO2
• Nasal Cannula (long-term)
– Infant - cat and small dogs (2-5 kg)
– Pediatric - medium dogs (11-24 kg)
– Adult - large dogs (>25 kg)
– Flow rate 50-100 mL/kg, up to 5-6L/min
– Provides at least 40% O2
Methods for Supplemental
O2 Delivery
• Transtracheal Catheter
– Patient with upper airway obstruction
– Large-bore over-the-needle catheter or commercial
tracheal catheter placed between tracheal rings in
midcervical region
– Humidify O2
• O2 Cage
– Easy
– Disadvantage - time it takes to oxygenate cage (up to
30 min to reach 45% at 15 L/min), inability to
evaluate/treat patient, opening doors for
evaluation/treatment
Methods for Supplemental
O2 Delivery
• Nasal Catheter (long-term)
– One of the most effective methods
– Red rubber tube placed in ventral nasal meatus and sutured to face
• Measure from tip of nose to lateral canthus
• 3.5-5 Fr - small dogs and cats
– 50 mL/kg/min
• 5-8 Fr - medium dogs
• 8 Fr - large dogs
– 100 mL/kg/min
– Provides 40-50% O2
• If higher flow rates needed,
– Place 2nd nasal catheter
– Nasopharyngeal O2 catheter
» Tip ends in proximal pharynx, ie. angle of mandible
» Provides 60-70% O2 at same flow rates as nasal catheter
– Nasotracheal O2 catheter
» Tip ends in proximal tracheal lumen, ie. level of thoracic inlet (elevated head to help facilitate
blind passage)
» Provides 80-90% O2 at 50% of nasal catheter flow rates
» Remember to humidify O2
– *Avoid in dogs w/ severe nasal/pharyngeal disease, thrombocytopenia, bleeding
disorders, head trauma (sneezing increases ICP)
REMEMBER…it’s simple physiology…
Preload
Contractility
Heart Rate
Afterload
Cardiac
Output
Goal #1: Reduce Congestion,
Edema, Effusions
• Reduce vascular volume (preload)
– Diuretics - Lasix
• Cats - 1-3 mg/kg IM/IV q1-2hr initially
• Dogs - 2-4mg/kg IM/IV q1-2hr initially
• Then reduce to 2 mg/kg TID-QID
• If RR/RE not improving to <40-50/min within 2-3 hours (ie. 2-3 doses), consider
additional therapies or incorrect Dx
– Nitroprusside +/- Dobutamine
• Morphine
– Anxiolytic and may increased pulmonary venous compliance
– Cats - 0.02-0.1 mg/kg IV q1-4hr; 0.2-0.5 mg/kg IM or SC q3-4hr
– Dogs - 0.1-1 mg/kg IV q1-4hr; 0.2-2 mg/kg IM or SC q2-4hr
• Reduce venous tone (vasodilators - increase venous capacitance)
– Pimobendan - 0.2-0.3 mg/kg PO BID
– Dobutamine - 1-10 mcg/kg/min (max. 5-8 in cats)
– Nitroglycerine - 1/4” small dog, 1/2’ large dog
Goal #1: Reduce Congestion,
Edema, Effusions
• Effusions
– If clinically significant, remove
– Pericardial effusion
• Caution in cats and small dogs…Why?
Goal #2: Improve CO
• Decrease Afterload
– Arterial vasodilators
• Hydralazine
– If BP >120 mmHg, ok to
give PO meds
– Monitor BP closely - want to
decrease ~15-20 mmHg
– Hydralazine - 0.5-1 mg/kg
PO QD-BID (cats -2.5 mg
PO BID)
– Balanced vasodilators
• Nitroprusside - 1-10
mcg/kg/min
– Light sensitive
– Monitor BP closely - titrate
q5-15 min
– Goal - maintain BP ~100
mmHg systolic
– Do NOT use >48 hours
• Increase Contractility
– Pimobendan
– Dobutamine
• Consider early in Tx plan if
DCM suspected
• Greatest clinical benefit
when left on CRI for 72hr,
then wean off over 8-12
hours
Pimobendan vs.
Dobutamine or Dopamine
• DoButamine
– B1 > B2 > A1
– Synthetic direct beta-1 agonist
– Mild beta-2 and alpha-1
• Balance effect on vasculature
– Strongest + inotrope available
– Less arrhythmogenic and
effect on HR
• DopAmine
– Beta; High dose alpha
– Precursor to NorEp
– Direct and indirect (via NE)
effects on alpha and beta-1
rec.
– More arrhythmogenic and
tachycardia-inducing
• Pimobendan
– Inodilator
• PDEIII inhibtor
• Ca sensitizer
–  Contractility
– Vasodilator
• Balanced systemic
• Pulmonary
–  Myocardial blood flow
–  LV filling pressures
– *Requires oral dosing and
absorption to be effective
Goal #3: Normalize HR
and Rhythm
• Arrhythmias further compromise cardiac function
– Atrial fibrillation
– VPCs / Vtach
• Stick to medications that do NOT significantly worsen
cardiac function
– Digoxin - 0.003-0.005 mg/kg of LBW PO BID
• Can “load” by giving 2x dose for 2 doses (ie. 24hr)
– Diltiazem - 0.5-2 mg/kg PO TID
– Mexilitine - 5-8 mg/kg PO TID
– Lidocaine - 40-80 mcg/kg/min
– (Sotalol) - 1-3 mg/kg PO BID
• Ideally know systolic function
• Beta-blockers are contraindicated in active CHF
Goal #3: Continued
• Atrial Fibrillation
– Digoxin in acute setting
• Primary SE = inappetance
– May present inappetant, but you can’t eat if you can’t breathe
– +/- Diltiazem
• Delay combination if inappetant
• If Pt laterally recumbent due to arrhythmia and unable to take oral
medications, can give diltiazem IV as CRI
– Bolus 0.1mg/kg SLOW (over 3 minutes)
– CRI 1-5 mcg/kg/min
– Do NOT expect conversion to NSR
– Goal is rate control
• < 160 bpm in stressful setting ultimately
• Start drugs low, then increase based on rate response every 24
hours
Goal #3: Continued
• Frequent VPCs or Vtach
– Reasons to Treat
• Sustained VTach = >160 bpm for 30 seconds
• R-on-T phenonenon (risk factor for VFib)
• Mutlifocal VPCs, Couplets, Triplets
– Lidocaine
• Bolus - 2 mg/kg IV slow (1-2 min)
– Repeat up to 4 times
• CRI - 40-80 mcg/kg/min
– Mexilitine
• 5-8 mg/kg PO TID
• Primary SE - GI - Recommend giving w/ food
• Start Mexitil prior to discontinuing Lidocaine
– Give 1st dose of Mexitil, wait 4-6 hours, then wean off Lidocaine
over 4-6 hours
Goal #4: Forward Failure,
Cardiogenic Shock
• Hypotension
– Systolic BP < 90 mmHg
– Consider dobutamine CRI
• CRI total volume should be <25% maintenance
fluid rates (ie. <15 mL/kg/d)
• What about hypotensive, dehydrated cats
in active CHF?
– IVF contraindicated
– NE tube fluids better tolerated
CHF and Cats
• Hypotensive + Hypothermic + Dehydrated
= Poor prognosis for short term survival
– Need NE tube for caloric and rehydration
needs
• Cats that do not respond to standard
therapy have a poor prognosis
• Cats are more sensitive to CRIs in general
– Nitroprusside can be useful
Comments / Questions
Contact Information:
info@cvcavets.com
www.cvcavets.com

More Related Content

Similar to CHFinSmallAnimalPractice_000.ppt

moduleiv-respiratoryemergencies-chf-copd-asthma.ppt
moduleiv-respiratoryemergencies-chf-copd-asthma.pptmoduleiv-respiratoryemergencies-chf-copd-asthma.ppt
moduleiv-respiratoryemergencies-chf-copd-asthma.pptRitikaNigam14
 
approach to congenital cyanotic heart diseases
approach to congenital cyanotic heart diseasesapproach to congenital cyanotic heart diseases
approach to congenital cyanotic heart diseasesRyanKhan40
 
Approach to congenital cyanotic heart diseases
Approach to congenital cyanotic heart diseases Approach to congenital cyanotic heart diseases
Approach to congenital cyanotic heart diseases Dr.Debasis Maity
 
Cardiac lecture pediatrics fall 2012
Cardiac lecture pediatrics fall 2012 Cardiac lecture pediatrics fall 2012
Cardiac lecture pediatrics fall 2012 JHU Nursing
 
Approach to congenital cyanotic heart diseases.pptx
Approach to congenital cyanotic heart diseases.pptxApproach to congenital cyanotic heart diseases.pptx
Approach to congenital cyanotic heart diseases.pptxMedicalSuperintenden19
 
MED Cvs
MED CvsMED Cvs
MED CvsO J
 
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disordersgchoyer
 
Percussion and Auscultation of CARDIOVASCULAR system.
Percussion and Auscultation of CARDIOVASCULAR system.Percussion and Auscultation of CARDIOVASCULAR system.
Percussion and Auscultation of CARDIOVASCULAR system.Manoz Marwin
 
chapter 3 CVS examination.pptx
chapter 3 CVS examination.pptxchapter 3 CVS examination.pptx
chapter 3 CVS examination.pptxAbdiIsaq1
 
Assessment Of Cardiovascular Function
Assessment Of Cardiovascular FunctionAssessment Of Cardiovascular Function
Assessment Of Cardiovascular FunctionTosca Torres
 
A Case of Dyspnoea
A Case of DyspnoeaA Case of Dyspnoea
A Case of Dyspnoeasranjan
 

Similar to CHFinSmallAnimalPractice_000.ppt (20)

moduleiv-respiratoryemergencies-chf-copd-asthma.ppt
moduleiv-respiratoryemergencies-chf-copd-asthma.pptmoduleiv-respiratoryemergencies-chf-copd-asthma.ppt
moduleiv-respiratoryemergencies-chf-copd-asthma.ppt
 
approach to congenital cyanotic heart diseases
approach to congenital cyanotic heart diseasesapproach to congenital cyanotic heart diseases
approach to congenital cyanotic heart diseases
 
Approach to congenital cyanotic heart diseases
Approach to congenital cyanotic heart diseases Approach to congenital cyanotic heart diseases
Approach to congenital cyanotic heart diseases
 
Cardiac lecture pediatrics fall 2012
Cardiac lecture pediatrics fall 2012 Cardiac lecture pediatrics fall 2012
Cardiac lecture pediatrics fall 2012
 
Cvd signs and symptoms
Cvd signs and symptoms Cvd signs and symptoms
Cvd signs and symptoms
 
Approach to congenital cyanotic heart diseases.pptx
Approach to congenital cyanotic heart diseases.pptxApproach to congenital cyanotic heart diseases.pptx
Approach to congenital cyanotic heart diseases.pptx
 
MED Cvs
MED CvsMED Cvs
MED Cvs
 
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disorders
 
Percussion and Auscultation of CARDIOVASCULAR system.
Percussion and Auscultation of CARDIOVASCULAR system.Percussion and Auscultation of CARDIOVASCULAR system.
Percussion and Auscultation of CARDIOVASCULAR system.
 
Cvs examination
Cvs examinationCvs examination
Cvs examination
 
Cvs examination ug
Cvs examination ugCvs examination ug
Cvs examination ug
 
Cvs examination ug 1
Cvs examination ug 1Cvs examination ug 1
Cvs examination ug 1
 
CVS
CVSCVS
CVS
 
chapter 3 CVS examination.pptx
chapter 3 CVS examination.pptxchapter 3 CVS examination.pptx
chapter 3 CVS examination.pptx
 
pericardial effusion
pericardial effusionpericardial effusion
pericardial effusion
 
Cardiac assessment
Cardiac assessmentCardiac assessment
Cardiac assessment
 
Assessment Of Cardiovascular Function
Assessment Of Cardiovascular FunctionAssessment Of Cardiovascular Function
Assessment Of Cardiovascular Function
 
cardiac assessment
cardiac assessment  cardiac assessment
cardiac assessment
 
A Case of Dyspnoea
A Case of DyspnoeaA Case of Dyspnoea
A Case of Dyspnoea
 
Cvs workshop
Cvs workshopCvs workshop
Cvs workshop
 

More from Imtiyaz60

asthma .pptx
asthma                                             .pptxasthma                                             .pptx
asthma .pptxImtiyaz60
 
Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptxImtiyaz60
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdfImtiyaz60
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptxImtiyaz60
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .pptImtiyaz60
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxImtiyaz60
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxImtiyaz60
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationImtiyaz60
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptxImtiyaz60
 
leprosy.pptx
leprosy.pptxleprosy.pptx
leprosy.pptxImtiyaz60
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptxImtiyaz60
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxImtiyaz60
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptxImtiyaz60
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxImtiyaz60
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptxImtiyaz60
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.pptImtiyaz60
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxImtiyaz60
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.pptImtiyaz60
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxImtiyaz60
 
rheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptxrheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptxImtiyaz60
 

More from Imtiyaz60 (20)

asthma .pptx
asthma                                             .pptxasthma                                             .pptx
asthma .pptx
 
Asthma and COPD PATHOPHYSIOLOGY .pptx
Asthma and COPD PATHOPHYSIOLOGY    .pptxAsthma and COPD PATHOPHYSIOLOGY    .pptx
Asthma and COPD PATHOPHYSIOLOGY .pptx
 
Angina and MI PATHOPHYSIOLOGY .pdf
Angina and MI PATHOPHYSIOLOGY       .pdfAngina and MI PATHOPHYSIOLOGY       .pdf
Angina and MI PATHOPHYSIOLOGY .pdf
 
ATHEROSCLEROSIS pathophysiology .pptx
ATHEROSCLEROSIS pathophysiology    .pptxATHEROSCLEROSIS pathophysiology    .pptx
ATHEROSCLEROSIS pathophysiology .pptx
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
 
Hypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptxHypertension and its pathophysiology.pptx
Hypertension and its pathophysiology.pptx
 
Appetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptxAppetite-stimulants-Digestants-and-carminatives.pptx
Appetite-stimulants-Digestants-and-carminatives.pptx
 
Anti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classificationAnti Ulcer drugs pharmacology and classification
Anti Ulcer drugs pharmacology and classification
 
gingerasafoetida.pptx
gingerasafoetida.pptxgingerasafoetida.pptx
gingerasafoetida.pptx
 
leprosy.pptx
leprosy.pptxleprosy.pptx
leprosy.pptx
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
strokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptxstrokepresentation-170712173032 (1).pptx
strokepresentation-170712173032 (1).pptx
 
Thyroid gland.pptx
Thyroid gland.pptxThyroid gland.pptx
Thyroid gland.pptx
 
inflammatory bowel diseas.pptx
inflammatory bowel diseas.pptxinflammatory bowel diseas.pptx
inflammatory bowel diseas.pptx
 
tannins-170116185017.pptx
tannins-170116185017.pptxtannins-170116185017.pptx
tannins-170116185017.pptx
 
Heart Failure.ppt
Heart Failure.pptHeart Failure.ppt
Heart Failure.ppt
 
tuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptxtuberculosiscompletednew-170308134731.pptx
tuberculosiscompletednew-170308134731.pptx
 
2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt2_2019_10_26!04_54_11_PM.ppt
2_2019_10_26!04_54_11_PM.ppt
 
Electrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptxElectrophysiology_of_Heart.pptx
Electrophysiology_of_Heart.pptx
 
rheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptxrheumatoidarthritispptbyann-160402080357.pptx
rheumatoidarthritispptbyann-160402080357.pptx
 

Recently uploaded

Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIShubhangi Sonawane
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 

Recently uploaded (20)

Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 

CHFinSmallAnimalPractice_000.ppt

  • 1. Emergency Management of Congestive Heart Failure in Small Animal Practice **Name**, DVM, DACVIM-Cardiology **Date**
  • 2. Outline • Cardiac Auscultation and History –Useful tools for distinguishing cardiac and respiratory disease • Radiographs • Pathophysiology of Heart Failure • Treatment of Heart Failure
  • 3. Cardic Auscultation: Tips • Take your time • Adequately restrain • Minimize panting, growling, purring • Focus on heart sounds first, breath sounds second • Develop a repeatable pattern • Listen for 3rd heart sounds (clicks, gallops) • Consider the signalment of the patient – Common things happen commonly – Congenital vs. Acquired – Breed-specific defects
  • 4. Cardiac Auscultation: Quick Review • Determine heart rate and rhythm • Correlate with femoral pulses • Auscult over all heart valves – Cranially - PDAs in big dogs • Normal Sounds – S1 - closure of MV and TV • Onset of systole • High frequency, PMI left apex • Pulse occurs just after S1 – S2 - closure of AoV and PV • Onset of diastole • High frequency, PMI left base
  • 5. Cardiac Auscultation: Quick Review • Transient Heart Sounds – Systolic Click • Dogs - usually associated with DMVD (prolapse of AMVL) • Cats - hyperdynamic function, systolic contact of LV walls – S3 Gallop (ventricular gallop) • Low frequency • Represents ventricular stiffness (diastolic dysfunction - reduced compliance while filling) • Caused by sudden termination of expansion of LV walls during period of rapid ventricular filling • HCM, DCM, Severe DMVD – S4 Gallop (atrial gallop) • Low frequency • Represents ventricular stiffness • Caused by atria trying to force blood into an already over-distended ventricle; atria forcing blood into stiff ventricle (atrial contraction - late ventricular diastole) • HCM • Can also hear S4 with some 3rd degree AVB
  • 6. Cardiac Auscultation: Quick Review • Heart Murmurs – Timing • Systolic - b/w S1 and S2 (“lub-shh-dub”) • Diastolic - after S2 (“lub-dub-shh”) • Continuous – PMI (base vs. apex, L vs R) – Intensity (I-VI) – Quality • Regurgitant = plateau shape – MR, TR • Ejection = crescendo-decrescendo – SAS, PS • Machinery (PDA) • Decrescendo (VSD, MR, TR)
  • 7. Cardiology Auscultation: Quick Review • I - faint, requires concentration/quiet room • II - soft, consistently ausculted over 1 valve area • III - radiates on the same side of the chest • IV - radiates to both sides of the chest • V - loud with palpable precordial thrill • VI - audible with stethoscope off chest wall
  • 8. Cardiac Auscultation: Summary • Slow down and take your time • It matters - YOU are the gate keeper • Making the correct diagnosis makes a difference in outcome and survival • 30% of Boxers, 1st sign to owner = SCD • Does the presence of crackles = CHF? • Document…Document…Document – Vital signs and trends matter – Can you explain changes? • If present, when did arrhythmia start?
  • 9. Dyspneic Patient: Recognizing Breathing Patterns • Upper Airway Disease – Obstructive breathing pattern • Long, slow inspiration – Exception - intrathoracic obstruction can cause expiratory distress – Narrowing of airway causes reduced and turbulent airflow – Animal works harder to breathe against obstruction exacerbating edema and inflammation - vicious cycle • Stridor or Stertor • Increased RE +/- abdominal component • Orthopnea – +/- Hyperthermia – Auscultation • Referred upper airway sounds, be sure to listen over trachea • Obstructions can cause non-cardiogenic pulmonary edema (crackles)
  • 10. Dyspneic Patient: Recognizing Breathing Patterns • Lower Airway Disease – Expiratory distress • Normal inspiration, exaggerated and prolonged expiration • Edema and cellular infiltrates of bronchiole walls lead to thickening and weakening of bronchial walls, excessive secretion, mucus plugs • Narrowing causes acute bronchospasm • As animal inhales, radial traction on the lungs pull the airways open and allows air to enter alveolus • As animal exhales, negative intrathoracic pressure causes airways to collapse, trapping air in alveolus – Alveolus full on next inspiration - reduced gas exchange – Marked expiratory abdominal “push” – Cats - cough (“coughing up hairballs”) – Auscultation • Expiratory wheezes • Loud crackles • No murmur – Exception - presence of cor pulmonale or concurrent cardiac disease
  • 11. Dyspneic Patient: Recognizing Breathing Patterns • Pulmonary Parenchymal Disease – No specific respiratory pattern – Respirations usually short, rapid, and deep • Can mimic nearly any respiratory pattern – +/- Abdominal component – Dogs - cough – Auscultation • Soft crackles – Sound of collapsed alveoli and lower airways “popping” open at end- inspiration (indicate fluid-filled alveoli) – Fluid - water, hemorrhage, pus • +/- Murmur
  • 12. Dyspneic Patient: Recognizing Breathing Patterns • Pleural Space Disease – Restrictive breathing pattern • Short, shallow, and rapid respirations – Presence of air/fluid/organs/masses prevents expansion of lungs – Intrapleural pressure > Intrapulmonary pressure » Causes increased tidal volume - animals must breathe faster that normal to maintain minute volume – Auscultation • Dull lung +/- heart sounds – Fluid - lungs loudest dorsal, dull ventral – Air - lungs loudest ventral, dull dorsal
  • 13. CARDIAC RESPIRATORY Cough Soft +/- productive (mucus) Occurs at rest Harsh/honking Occurs w/ activity/excitement Activity  +/- Exercise intolerance Normal Weight/BCS +/- Weight loss +/- Obese Lungs Sounds Normal to  BV sounds +/- Soft crackles (dyspneic)  BV sounds (pleural effusion) Normal to  BV sounds +/- Loud crackles (eupneic) +/- Wheezes RR/RE/Pattern Usually short, rapid, deep +/- abdominal effort Exaggerated, prolonged expiration +/- exp abd. push HR/Rhythm Normal to Sinus Tachycardia Possible arrhythmia Normal to sinus bradycardia +/- RSA Murmur Often L apex in dogs +/- Cor pulmonale, Concurrent cardiac disease (R vs L?) CXR Interstitial to alveolar pattern LAE Bronchial and nodular patterns - unlikely CHF Bronchial, Broncho-interstitial pattern Peri-bronchial enhancement
  • 14. Cardiac vs. Respiratory - Dogs • Causes of dyspnea – Bronchitis – Collapsing airway disorders – Pulmonary interstitial disease (IPF) – Pulmonary hypertension – Pneumonia • Cardiac cough = “hack/gag” – Cardiomegaly and bronchial compression – RR should be normal • Sequence of pulmonary edema: – Perihilar  Cd-D (R then L) Cr-V – Resolves in reverse order w/ Tx
  • 15. Cardiac vs. Respiratory - Cats • Causes of Dyspnea – CHF – Asthma / Inflammatory bronchial disease – Mycoplasma – Pneumonia • CHF Origin Pulmonary Infiltrates (usually) – Cardiomegaly – No bronchial pattern – Can put edema anywhere • Cardiac Origin Pleural Effusion – TP < 4.5 g/dL – Mixed cell population with low TCC – No bacteria • Arrhythmias – CV disease – Hypoxia (global or local) – Metabolic disease – Drugs / Toxins – Infection (sepsis) – Autonomic disease (usuall diagnosis of exclusion
  • 16. History and Presenting Complaint • Early Signs of CHF – Dogs • Exercise intolerance • +/-Coughing – Cats • Hiding, decreased appetite, behavioral change – Both • Increase sleeping/resting RR • Late Signs of CHF – Rapid breathing – Exaggerated chest and abdominal motion to respiration – Extended head/neck – Coughing up pink foam (pulmonary edema)
  • 18. Chest Radiographs: Quick Review • <3 ICS - Avg Dog – <3.5 - Small Breeds – < 2.5 - Deep-Chested • A = 1/3-1/4 (A+B) • B = 2/3-3/4 (A+B) • Cats - <70% height of chest; < 2-3 ICS • Greatest horizontal dimension should be <2/3 chest dimension at that location • Cats - <50% width of chest
  • 19. Chest Radiographs: Quick Review • Normal dogs: 8.5-10.7 (9.7 +/- 0.5) • Boxers: 10.3-12.6 • Labrador Retrievers: 9.7-11.7 • CKCS: 9.9-11.7 • Cats: 6.7-8.1 (mean 7.5)
  • 20. Cat in a Box Radiograph Trick
  • 22. Congestive Heart Failure • Syndrome, not a disease – Abnormality of cardiac function that results in the failure of the heart to pump blood at a rate commensurate with requirements of metabolizing tissues
  • 23. CHF - Classification • Forward Failure – Signs result from low CO and inadequate tissue perfusion – Weakness, lethargy, pre-renal azotemia • Backward Failure – Failure of heart to empty blood from the veins - leading to elevated venous and capillary pressures – Pulmonary edema, ascites, pleural effusion • Cardiogenic Shock – Signs of forward and backward failure + systemic hypotension
  • 24. CHF: Classification NYHA Class I (Mild) Asymptomatic; Heart disease present but no CS Class II (Mild) CS present with strenuous activity; Comfortable at rest Class III (Moderate) CS with routine daily activities and mild exercise; Comfortable at rest Class IV (Severe) CS severe, even at rest; Requires hospitalization ACVIM 2009 Consensus Statement A Dogs are risk for CHF; No apparent structural abnormality; No murmur B-1 Structural heart disease present; Never had signs of CHF; Asymptomatic B-2 Asymptomatic; Hemodynamically significant, remodeling noted on echo C Past or current signs of CHF assoc w/ structural heart disease D End stage heart disease; CHF refractory to standard therapy
  • 25. CHF - Mechanisms • 5 Mechanisms of CHF – Volume overload • MR, PDA – Pressure overload • SAH, SAS, PS – Myocardial failure • DCM – Diastolic dysfunction • HCM – Arrhythmias • AFib, SVT, VT
  • 26. CHF - CV System Priorities • Priorities of the CV System – Maintain normal systemic BP – Maintain normal tissue blood flow – Maintain normal systemic and pulmonary capillary pressures • Why does the CV system have priorities? – 3 critical vascular beds in the body (brain, heart, kidneys) have high innate resistance to blood flow • Ie. They need high pressures to force blood through them
  • 27. CHF - Consequences • CHF results in reduction of cardiac output - triggers cascades of physiologic events to restore BP (CV System 1st priority) – Sympathetic stimulation of the heart – Vasoconstriction – Redistribution of blood flow • SNS • RAAS • Vasopressin • Vascular endothelial systems – Na/H2O Retention • Changes in RBF • Aldosterone • Vasopressin • Inhibition of natriuretic hormones
  • 28. CHF - Systems altered… What’s the harm? • So, if these events are beneficial, why do we try to block them with medications? – No permanent harm if systems return to normal – Chronic activation - physiologic balance shifts toward • Vasoconstriction • Na retention • Mediators of inflammation • Mediators of tissue growth • Remodeling/fibrosis – Structural and functional damage to heart muscle
  • 29. CHF - ER Management • Goals – Reduce venous congestion, edema, and effusion formation – Increase CO – Normalize HR and rhythm – Address forward failure signs (hypotension, hypothermia) • O2 – Pulmonary edema can case life-threatening hypoxemia d/t decreased ability of O2 to diffuse from alveoli into pulmonary capillaries – Increased inspired O2 concentration increases pressure gradient of O2 from alveoli to capillaries – Emergency - 60-100% FiO2 – Chronic O2 therapy - 35-40% FiO2
  • 30. Methods for Supplemental O2 Delivery • Blow-by O2 • O2 Hood (temporary treatment) – Place head inside plastic bag; O2 tubing through small hole in front of bag; Back of bag left open for gas to escape; Monitor temp. – Provides 85-95% O2 • O2 Collar (short or long-term treatment) – Cover ventral 50-75% E-collar with plastic wrap; E-collar should be 1 size larger than normally used; O2 tubing placed along inside of collar and taped ventrally – O2 concentration up to 80% can be achieved – Flow rate of 1L / 10kg of BW usually provides adequate FiO2 • Nasal Cannula (long-term) – Infant - cat and small dogs (2-5 kg) – Pediatric - medium dogs (11-24 kg) – Adult - large dogs (>25 kg) – Flow rate 50-100 mL/kg, up to 5-6L/min – Provides at least 40% O2
  • 31. Methods for Supplemental O2 Delivery • Transtracheal Catheter – Patient with upper airway obstruction – Large-bore over-the-needle catheter or commercial tracheal catheter placed between tracheal rings in midcervical region – Humidify O2 • O2 Cage – Easy – Disadvantage - time it takes to oxygenate cage (up to 30 min to reach 45% at 15 L/min), inability to evaluate/treat patient, opening doors for evaluation/treatment
  • 32. Methods for Supplemental O2 Delivery • Nasal Catheter (long-term) – One of the most effective methods – Red rubber tube placed in ventral nasal meatus and sutured to face • Measure from tip of nose to lateral canthus • 3.5-5 Fr - small dogs and cats – 50 mL/kg/min • 5-8 Fr - medium dogs • 8 Fr - large dogs – 100 mL/kg/min – Provides 40-50% O2 • If higher flow rates needed, – Place 2nd nasal catheter – Nasopharyngeal O2 catheter » Tip ends in proximal pharynx, ie. angle of mandible » Provides 60-70% O2 at same flow rates as nasal catheter – Nasotracheal O2 catheter » Tip ends in proximal tracheal lumen, ie. level of thoracic inlet (elevated head to help facilitate blind passage) » Provides 80-90% O2 at 50% of nasal catheter flow rates » Remember to humidify O2 – *Avoid in dogs w/ severe nasal/pharyngeal disease, thrombocytopenia, bleeding disorders, head trauma (sneezing increases ICP)
  • 34. Goal #1: Reduce Congestion, Edema, Effusions • Reduce vascular volume (preload) – Diuretics - Lasix • Cats - 1-3 mg/kg IM/IV q1-2hr initially • Dogs - 2-4mg/kg IM/IV q1-2hr initially • Then reduce to 2 mg/kg TID-QID • If RR/RE not improving to <40-50/min within 2-3 hours (ie. 2-3 doses), consider additional therapies or incorrect Dx – Nitroprusside +/- Dobutamine • Morphine – Anxiolytic and may increased pulmonary venous compliance – Cats - 0.02-0.1 mg/kg IV q1-4hr; 0.2-0.5 mg/kg IM or SC q3-4hr – Dogs - 0.1-1 mg/kg IV q1-4hr; 0.2-2 mg/kg IM or SC q2-4hr • Reduce venous tone (vasodilators - increase venous capacitance) – Pimobendan - 0.2-0.3 mg/kg PO BID – Dobutamine - 1-10 mcg/kg/min (max. 5-8 in cats) – Nitroglycerine - 1/4” small dog, 1/2’ large dog
  • 35. Goal #1: Reduce Congestion, Edema, Effusions • Effusions – If clinically significant, remove – Pericardial effusion • Caution in cats and small dogs…Why?
  • 36. Goal #2: Improve CO • Decrease Afterload – Arterial vasodilators • Hydralazine – If BP >120 mmHg, ok to give PO meds – Monitor BP closely - want to decrease ~15-20 mmHg – Hydralazine - 0.5-1 mg/kg PO QD-BID (cats -2.5 mg PO BID) – Balanced vasodilators • Nitroprusside - 1-10 mcg/kg/min – Light sensitive – Monitor BP closely - titrate q5-15 min – Goal - maintain BP ~100 mmHg systolic – Do NOT use >48 hours • Increase Contractility – Pimobendan – Dobutamine • Consider early in Tx plan if DCM suspected • Greatest clinical benefit when left on CRI for 72hr, then wean off over 8-12 hours
  • 37. Pimobendan vs. Dobutamine or Dopamine • DoButamine – B1 > B2 > A1 – Synthetic direct beta-1 agonist – Mild beta-2 and alpha-1 • Balance effect on vasculature – Strongest + inotrope available – Less arrhythmogenic and effect on HR • DopAmine – Beta; High dose alpha – Precursor to NorEp – Direct and indirect (via NE) effects on alpha and beta-1 rec. – More arrhythmogenic and tachycardia-inducing • Pimobendan – Inodilator • PDEIII inhibtor • Ca sensitizer –  Contractility – Vasodilator • Balanced systemic • Pulmonary –  Myocardial blood flow –  LV filling pressures – *Requires oral dosing and absorption to be effective
  • 38. Goal #3: Normalize HR and Rhythm • Arrhythmias further compromise cardiac function – Atrial fibrillation – VPCs / Vtach • Stick to medications that do NOT significantly worsen cardiac function – Digoxin - 0.003-0.005 mg/kg of LBW PO BID • Can “load” by giving 2x dose for 2 doses (ie. 24hr) – Diltiazem - 0.5-2 mg/kg PO TID – Mexilitine - 5-8 mg/kg PO TID – Lidocaine - 40-80 mcg/kg/min – (Sotalol) - 1-3 mg/kg PO BID • Ideally know systolic function • Beta-blockers are contraindicated in active CHF
  • 39. Goal #3: Continued • Atrial Fibrillation – Digoxin in acute setting • Primary SE = inappetance – May present inappetant, but you can’t eat if you can’t breathe – +/- Diltiazem • Delay combination if inappetant • If Pt laterally recumbent due to arrhythmia and unable to take oral medications, can give diltiazem IV as CRI – Bolus 0.1mg/kg SLOW (over 3 minutes) – CRI 1-5 mcg/kg/min – Do NOT expect conversion to NSR – Goal is rate control • < 160 bpm in stressful setting ultimately • Start drugs low, then increase based on rate response every 24 hours
  • 40. Goal #3: Continued • Frequent VPCs or Vtach – Reasons to Treat • Sustained VTach = >160 bpm for 30 seconds • R-on-T phenonenon (risk factor for VFib) • Mutlifocal VPCs, Couplets, Triplets – Lidocaine • Bolus - 2 mg/kg IV slow (1-2 min) – Repeat up to 4 times • CRI - 40-80 mcg/kg/min – Mexilitine • 5-8 mg/kg PO TID • Primary SE - GI - Recommend giving w/ food • Start Mexitil prior to discontinuing Lidocaine – Give 1st dose of Mexitil, wait 4-6 hours, then wean off Lidocaine over 4-6 hours
  • 41. Goal #4: Forward Failure, Cardiogenic Shock • Hypotension – Systolic BP < 90 mmHg – Consider dobutamine CRI • CRI total volume should be <25% maintenance fluid rates (ie. <15 mL/kg/d) • What about hypotensive, dehydrated cats in active CHF? – IVF contraindicated – NE tube fluids better tolerated
  • 42. CHF and Cats • Hypotensive + Hypothermic + Dehydrated = Poor prognosis for short term survival – Need NE tube for caloric and rehydration needs • Cats that do not respond to standard therapy have a poor prognosis • Cats are more sensitive to CRIs in general – Nitroprusside can be useful
  • 43. Comments / Questions Contact Information: info@cvcavets.com www.cvcavets.com